Table 2.
Exposure of PS on red cells from normal controls and patients
| Patient | Diagnosis | % of cells with exposed PS |
|---|---|---|
| 1 | Hemolytic anemia | 0.00 |
| 2 | Hemolytic anemia | 0.00 |
| Ctrl1 | Normal control | 0.10 |
| 3 | Hemolytic anemia (G6PD deficiency) | 0.11 |
| 4 | Hemolytic anemia | 0.13 |
| 5 | Hemolytic anemia | 0.13 |
| 6 | Hemolytic anemia (G6PD deficiency: A-) | 0.15 |
| 7 | Hemolytic anemia (PK deficiency) | 0.17 |
| Ctrl2 | Normal control | 0.18 |
| 8 | Hemolytic anemia (Hereditary spherocytosis) | 0.23 |
| Ctrl3 | Normal control | 0.29 |
| Ctrl4 | Normal control | 0.42 |
| Ctrl5 | Normal control | 0.42 |
| Ctrl6 | Normal control | 0.43 |
| 9 | Hemolytic anemia | 0.53 |
| Ctrl7 | Normal control | 0.53 |
| 10 | Hemolytic anemia | 0.56 |
| 11 | Hemolytic anemia | 0.56 |
| 12 | Lymphoma* | 0.69 |
| Ctrl8 | Normal control | 0.83 |
| 13 | Gaucher disease* | 1.16 |
| 14 | Hemolytic anemia (PK deficiency) | 1.51 |
| 15 | Hemolytic anemia (unstable hemoglobin)* | 3.72 |
| 16 | Hemolytic anemia (unstable hemoglobin)* | 6.78 |
Patients shown in boldface type have an elevated (>1%) percentage of cells exposing PS.
*
Patient had a splenectomy.